INDIANAPOLIS -- The latest weapon against inoperable liver cancer is so tiny that it takes millions of them per treatment, but according to interventional radiologists at the Indiana University School ...

The latest weapon against inoperable liver cancer is so tiny that it takes millions of them per treatment, but according to interventional radiologists, those microscopic spheres really pack a ...

This was a prospective single-centre, phase I study to document the maximum tolerated dose (MTD), dose-limiting toxicity (DLT), and the recommended phase II dose for future study of capecitabine in ...

使用钇-90（90Y）树脂微球进行放射性肝段切除术（Radiation Segmentectomy，RS）时，以往主要通过体表面积或分区模型来确定治疗所需的辐射剂量活度，存在处方活度较低的情况。近年来，有研究采用单室医学内部辐射剂量测定法（Medical internal radiation dosimetry，MIRD ...

Peritoneal carcinomatosis from colorectal cancer: Not a lost cause. Background: Y-90 radioembolization has shown promise in the treatment of unresectable metastatic colorectal cancer (mCRC) and ...

FOLFIRINOX versus gemcitabine nab-paclitaxel for advanced pancreatic cancer: KU Cancer Center experience. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This abstract does not ...

May 3, 2009 (Copenhagen, Denmark) — A phase 2 study of radioembolization with yttrium-90 has shown it to be effective and safe for the treatment of advanced hepatocellular carcinoma (HCC), with or ...

A minimally invasive treatment that delivers cancer-killing radiation directly to tumors shows promise in treating breast cancer that has spread to the liver when no other treatment options remain.

A steerable, guidewireless microcatheter is of interest to interventional radiologists because it can improve effectiveness and reduce procedure timing and cost. To assess the feasibility and safety ...

Background. A 58-year-old white man who was being followed by his hepatologist for nonalcoholic steatohepatitis-related liver cirrhosis and portal hypertension and who had been found to have a ...

Largest study of its kind shows minimally invasive treatment may slow disease progression in liver while maintaining quality of life SAN DIEGO (March 24, 2014)—A minimally invasive treatment that ...